News

More Trump administration figures who met Laura Loomer’s ire are out. A look at her influence
President Donald Trump has downplayed the influence of Laura Loomer, a right-wing provocateur known for her incendiary social ...
Patients still benefit from Eisai and Biogen Alzheimer's drug after four years, study finds
Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...
Confusion at NIH as administration halts, then releases, billions of dollars for scientific research
Billions of dollars of NIH research were stuck in limbo for hours after OMB directed the agency to halt further funding and ...
Trump Administration Live Updates: President Escalates Brazil Feud With Tariffs and Sanctions
The Food and Drug Administration’s top vaccine and gene therapy official resigned on Tuesday after a public campaign against ...
The Sarepta Mugging and Drug Innovation
The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
Is the FDA Doing Enough About Food Additives?
Food dyes are known to have a wide range of impacts on health, such as cancer risks, behavioral problems in children, and ...
FDA commissioner predicts ‘record’ drug approvals this year
FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...
KSAT1h
FDA warns about possible E. coli, Salmonella infection found in pet food sold online
The U.S. Food and Drug Administration (FDA) is issuing a warning to pet owners that certain dog food from last year may be ...
FDA calls for illicit drug scheduling of high-dose kratom plant extract 7-OH
The Trump administration is recommending that a compound called 7-OH be scheduled as an illicit drug, Food and Drug ...
STAT6h
FDA names drug regulator Tidmarsh acting head of biologics center after Prasad’s exit
George Tidmarsh is taking on more responsibilities at FDA after the sudden departure of top official Vinay Prasad.